KARA MUDD: Open Payments
NPI 1730374794 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$38,826 in 197 payments from 20 companies in 2025. Trend: 2023 $16,787 · 2024 $36,443 · 2025 $38,826
Speaker / faculty: $25,541Consulting: $5,495Food & beverage: $4,659Honoraria: $2,800Education: $168Travel & lodging: $163
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 23 | $14,469 |
| Incyte Corporation | 19 | $6,553 |
| Regeneron Healthcare Solutions, Inc. | 24 | $5,278 |
| Organon LLC | 5 | $2,956 |
| UCB, Inc. | 18 | $2,708 |
| Novartis Pharmaceuticals Corporation | 13 | $1,953 |
| Regeneron Pharmaceuticals, Inc. | 4 | $1,719 |
| Galderma Laboratories, L.P. | 14 | $1,492 |
| ABBVIE INC. | 29 | $476 |
| Arcutis Biotherapeutics, Inc. | 6 | $230 |
Products named: DUPIXENT, Opzelura, VTAMA, Bimzelx, NEMLUVIO, SKYRIZI, ANZUPGO, TREMFYA.
Industry payments across KY — which companies pay providers there.
